Vaccines for the Developing World: The Challenge to Justify Tiered Pricing Case Solution
This microeconomics instance analyzes the pricing issues associated with the sale of low-cost vaccines to be used in developing countries. The instance describes the historical success of the United Nations' so called "tiered costing" policy.
This rule coerced World Health Organization to buy large quantities of vaccines at the marginal price of vaccine generation-often just a couple of cents per dose-while the total average cost was paid by developed countries - often. Shifting political conditions and the price construction of new vaccines endanger the decades-old organization, yet. HKS Instance Number 1450.0
This is just an excerpt. This case is about FINANCE & ACCOUNTING
PUBLICATION DATE: November 01, 1997
Related Case Solutions & Analyses:
Cardinal Health Inc. (A)
Central Bank: The ChexSystems(SM) QualiFile(R) Decision
Introduction to Responsibility Accounting Systems Online Tutorial
Assessing Earnings Quality: Nuware Inc.
Southeastern Asset Management Challenges Buyout at Dell
Sack It & Pack It, Inc.: 12 Combinations of GAAP and How They Differ
Trichromatic West Inc.
Kim Park (A): Long-lived Nonmonetary Assets
Monsanto Company
American Apparel: Drowning in Debt?
